Article
Dual-regulated myoD- and msx1-based interventions in C2C12-derived cells enable precise myogenic/osteogenic/adipogenic lineage control.
The journal of gene medicine - 1 Oct 2004
Fux Cornelia, Langer Dominik, Fussenegger Martin
Abstract excerpt
BACKGROUND: Advanced gene therapy, tissue engineering and biopharmaceutical manufacturing require sophisticated and well-balanced multiregulated multigene interventions to reprogram desired mammalian cell phenotypes. METHODS: We have combined the streptogramin (PIP)- and tetracycline (TET)-responsive gene regulation systems for independent expression control of the differentiation determinants myoD and msx1 in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
